Pulmonary embolism
534 results
201 - 300
Guidelines for managing VTE (AAFP, ACP)- Rosuvastatin prevents DVT at very high cost
- Aspirin prevents recurrent venous thromboembolism
Oncological emergencies - ACCP 2016: updated guidelines for VTE
- Guidelines for the clinical diagnosis of VTE (AAFP, ACP)
- Prevention of venous thromboembolism
Statins for primary prevention of venous thromboembolism: Cochrane systematic review- Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and myocardial infarction)
- Acute coronary syndrome
- Antithrombotic agents in primary health care
- Chronic diseases and pregnancy
- Optimal dosing for thromboprophylaxis in medical inpatients
- Anticoagulant therapy for deep vein thrombosis (DVT) in pregnancy: Cochrane systematic review
- Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement: Cochrane systematic review
- Nephrotic syndrome
- Prolonged fever in the adult
- Diving medicine
- Testosterone does not increase major adverse cardiac events, but does increase risk of AFib, PE, acute kidney injury, and arrhythmia (TRAVERSE)
- Fixed-dose, subcutaneous, unfractionated heparin effective for VTE
- Oral rivaroxaban as effective as standard therapy for treatment of acute PE
- Temporary IVC filter added to anticoagulation does not decrease risk of PE recurrence
- Menopausal symptoms and hormone therapy
- Anaphylaxis
- Delirium in the elderly
- Dyspnoea
- Fondaparinux effective for superficial thrombosis but at very high cost
- Compression stockings for preventing deep vein thrombosis in airline passengers
- Thromboembolism recurrence likely; consider it a chronic disease (MARVELOUS)
- Enoxaparin better than aspirin for prevention of venous thromboembolism after total hip or knee arthroplasty
- Differential diagnostics of episodic symptoms
- Chronic heart failure
- Warfarin therapy
- Genotype-guided perioperative warfarin dosing may not be superior to algorithm-guided dosing
- Clinical rule to identify patients at low risk of recurrent VTE
- Thrombolysis for PE reduces rate of all-cause mortality but increases risk of major bleeding
- Prehospital emergency care
- Dalteparin = unfractionated heparin for ICU DVT prophylaxis
- Patients with initial unprovoked DVT or PE benefit from long-term low-dose aspirin (INSPIRE)
- Continuing warfarin for 18 months after unprovoked PE reduces risk of recurrent VTE
- Low molecular weight heparin in patients with lower-leg immobilization
- Extended anticoagulation may be helpul for patients with unprovoked VTE or PE
- Tranexamic acid may reduce bleeding after cesarean delivery, but with a risk of adverse effects
- Multidetector CT accurate for PE, but requires clinical context
- Fibrinolysis for intermediate-risk PE: increased bleeding, no mortality effect
- Heparins and mechanical methods for thromboprophylaxis in colorectal surgery
- 20 mcg versus over 20 mcg estrogen combined oral contraceptives for contraception
- Third-generation oral contraceptives associated with greater risk of PE, stroke, and MI
- Haemoptysis
- Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis
- Anticoagulants for people hospitalised with COVID‐19
- Interventions for preventing venous thromboembolism following abdominal aortic surgery
- Low-molecular-weight heparins vs. standard heparin for acute ischaemic stroke
- Increasing the D-dimer threshold for patients with low clinical pretest probability effectively rules out PE (PEGeD)
- Warfarin: damned if you do, damned if you don't
- Both upper-extremity and lower-extremity DVT risk increased with PICCs
- Echocardiography as an outpatient procedure
- Apixaban slightly more effective and safe than warfarin, but more expensive
- Anticoagulation for cerebral venous sinus thrombosis: Cochrane systematic review
- Low-risk patients with PE can be treated as outpatients
- IPC safer and as effective as medical prophylaxis; much better than TEDS
- Deep vein thrombosis
- Risk of myocardial infarction in users of third generation oral contraceptives
- Thrombolysis for acute upper extremity deep vein thrombosis
- Oral anticoagulation for prolonging survival in patients with cancer
- Interrupted versus uninterrupted anticoagulation for cardiac rhythm management device insertion
- No decrease in all-cause mortality with LMWH for VTE prophylaxis in hospitalized medical patients
- Acute abdomen in the adult
- Dabigatran safe and effective for VTE
- ACP Guideline: Universal VTE prophylaxis not recommended for hospitalized medical and stroke patients
- Low rate of symptomatic VTE after elective knee arthroscopy
- Anticoagulation for perioperative thromboprophylaxis in people with cancer
- In-flight medical emergencies
- Combined oral contraceptives: venous thrombosis: Cochrane systematic review
- Prolonged thromboprophylaxis after hip-replacement surgery decreases VTE
- Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism
- Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism
- Stockings plus anticoagulation more effective to prevent post-op VTE, but anticoagulation increases bleeding
- Prognostic accuracy of imaging findings for predicting morbidity and mortality in patients with COVID‐19
- Topical application of tranexamic acid for the reduction of bleeding
- Tranexamic acid for reducing mortality in emergency and urgent surgery
- Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy
- Dabigatran versus LMWHs for thromboprophylaxis after total hip or knee replacement
- Rivaroxaban is effective and safe for thromboprophylaxis after bariatric surgery
- Obesity not associated with adverse hip replacement outcomes